Organon and Sareum announce research collaboration in autoimmune disease
20-Jan-2006
Sareum will endeavor to determine the three-dimensional structures of two of the Organon autoimmune disease protein targets and then deploy its innovative Template Screening method to identify novel compounds suitable for optimization into lead drug candidates, using its automated medicinal chemistry platform. In return, Sareum will receive research fees and success milestone payments. Financial details were not disclosed.
Topics
Organizations
AkzoNobel
N.V. Organon
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.